Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
De-escalation, Recovery, and Safe Transition of Care

De-escalation, Recovery, and Safe Transition of Care

Objective Icon A clipboard with a checkmark, symbolizing a structured plan.

Objective

Develop a structured plan to facilitate patient recovery, mitigate long-term complications, and ensure a safe transition of care after acute overdose management.

Learning Points:

  • Outline a protocol for weaning intensive therapies as organ function recovers.
  • Formulate a plan for converting from IV to enteral medications.
  • Identify high-risk patients for Post-ICU Syndrome (PICS) and implement the ABCDEF bundle.
  • Structure a comprehensive medication reconciliation and discharge counseling plan.

1. Weaning and De-escalation Protocols

As toxicity resolves and organ function improves, structured criteria must guide the discontinuation of renal replacement therapy (RRT), vasopressors, and mechanical ventilation. This systematic approach reduces ICU-acquired complications and accelerates recovery.

A. Criteria for Discontinuing RRT and Vasopressors

Timely removal of supportive measures is crucial once the patient demonstrates sustained improvement.

  • RRT Cessation: Consider stopping when the patient achieves a sustained urine output of ≥0.5 mL/kg/h for 24 hours without diuretic support, coupled with stable electrolytes and acid-base balance while off dialysis.
  • Vasopressor Weaning: Initiate weaning when the mean arterial pressure (MAP) is consistently ≥65 mm Hg on a minimal vasopressor dose (e.g., norepinephrine ≤0.05 mcg/kg/min), with evidence of improving perfusion such as lactate clearance and normalized urine output.
Pearl Icon A lightbulb, indicating a clinical pearl or key insight. Clinical Pearl: De-escalation Huddles +

Daily multidisciplinary review of renal and hemodynamic parameters is essential. Formalizing this with a “de-escalation huddle” involving pharmacy, nursing, and medical staff can accelerate the timely discontinuation of therapies and prevent unnecessary ICU days.

B. Sequential Ventilator Weaning Steps

Protocolized liberation from mechanical ventilation involves daily readiness screens, spontaneous breathing trials (SBTs), and minimizing sedation to improve outcomes.

  1. Assess Readiness for Weaning: Daily screening is key. Patients should meet criteria such as pH ≥7.30, FiO₂ ≤0.40, PEEP ≤8 cm H₂O, and hemodynamic stability without escalating vasopressor support.
  2. Conduct a Spontaneous Breathing Trial (SBT): If ready, perform an SBT using a T-piece or minimal pressure support. Success is indicated by a rapid shallow breathing index (RSBI) <105 breaths/min/L and no signs of distress (e.g., tachycardia, diaphoresis, anxiety).
  3. Evaluate for Extubation: Before extubation, perform a cuff-leak test, especially in patients at risk for airway edema, to ensure airway patency.
Pearl Icon A lightbulb, indicating a clinical pearl or key insight. Clinical Pearl: Early SBTs +

Implementing protocols that mandate early, daily SBTs for all eligible patients has been shown to significantly shorten the duration of mechanical ventilation without increasing the risk of reintubation.

C. Transition from IV to Enteral Medications

Converting medication routes requires a careful assessment of gastrointestinal function, drug bioavailability, and appropriate dosing strategies to maintain therapeutic efficacy and avoid errors.

IV to Enteral Medication Conversion Strategies
Oral Bioavailability Recommended Enteral Dose (% of IV Dose) Key Considerations
>90% (High)
(e.g., levetiracetam, linezolid, fluoroquinolones)
75–100% Direct conversion is generally safe. Consider 75% dose for frail patients or if GI absorption is questionable.
50–90% (Intermediate)
(e.g., metoprolol, hydralazine)
100–150% Requires careful titration. Start at 100-150% of the total daily IV dose, divided appropriately, and monitor clinical response.
<50% (Low/Poor)
(e.g., furosemide, many antipsychotics)
≥200% or Avoid Conversion is often unreliable. May require significantly higher doses. Therapeutic drug monitoring is advised if available. Consider alternative agents.
Pearl Icon A lightbulb, indicating a clinical pearl or key insight. Clinical Pearl: Protocolize Conversions +

Standardized IV-to-enteral conversion protocols embedded within electronic health record order sets can dramatically reduce dosing errors and streamline the transition process for nursing and pharmacy staff.

2. Post-ICU Syndrome (PICS) Mitigation

Post-ICU Syndrome (PICS) is a constellation of new or worsened physical, cognitive, and psychological impairments that persist after critical illness. Proactive risk stratification and consistent implementation of the ABCDEF bundle are the most effective strategies to attenuate these long-term sequelae.

A. Identification of High-Risk Patients

Early identification allows for targeted interventions. Key risk factors include:

  • Prolonged mechanical ventilation (>7 days)
  • Presence of documented delirium (formally screened with CAM-ICU or ICDSC)
  • Use of deep sedation or prolonged benzodiazepine infusions
  • Advanced age (>65 years) and pre-existing comorbidities

B. Implementation of the ABCDEF Bundle

The ABCDEF bundle is a multicomponent, evidence-based strategy that improves patient outcomes, including survival, and reduces delirium, mechanical ventilation duration, and ICU costs.

ABCDEF Bundle for ICU Care A flowchart illustrating the six components of the ABCDEF bundle: A for Assess Pain, B for Both Spontaneous Awakening and Breathing Trials, C for Choice of Sedation, D for Delirium Assessment, E for Early Mobility, and F for Family Engagement. A Assess, Prevent & Manage Pain Use CPOT/BPS tools. Prioritize non-opioids. B Both Spontaneous Awakening & Breathing Daily coordinated sedation holds and SBTs. C Choice of Analgesia & Sedation Avoid benzodiazepines. Prefer propofol/dex. D Delirium: Assess, Prevent & Manage Screen with CAM-ICU. Use non-pharm methods. E Early Mobility & Exercise Progress from passive ROM to ambulation. F Family Engagement & Empowerment Involve in rounds, care, and goal-setting.
Figure 1: The ABCDEF Bundle. A systematic, interprofessional approach to ICU care that humanizes the patient experience and has been proven to reduce delirium, shorten ICU stays, and improve long-term outcomes for survivors of critical illness.
Pearl Icon A lightbulb, indicating a clinical pearl or key insight. Clinical Pearl: Bundle Adherence is Key +

The benefits of the ABCDEF bundle are most pronounced when adherence is high across all components. Focusing on just one or two elements is less effective. Consistent, team-wide adoption is necessary to realize the full impact on reducing delirium and improving patient recovery trajectories.

3. Medication Reconciliation and Discharge Planning

A safe transition from hospital to home is paramount. Pharmacist-led medication reconciliation and targeted patient counseling are high-impact interventions that minimize adverse drug events and support continuity of care after a complex hospitalization.

A. Comprehensive Medication Review and Error Prevention

The transition of care is a high-risk period for medication errors. A systematic process is required to ensure accuracy.

  • Reconcile Lists: Meticulously compare the patient’s pre-admission medication list, all inpatient orders, and the planned discharge regimen to identify and resolve discrepancies.
  • Verify Information: Confirm allergies and screen for therapeutic duplications, especially for high-risk agents like opioids, sedatives, and anticoagulants.
  • Leverage Technology: Use electronic health record (EHR) tools and clinical decision support to flag potential interactions or unsafe prescriptions.

B. Patient and Caregiver Counseling

Effective education empowers patients to manage their health safely after discharge.

  • Employ Teach-Back: Ask the patient or caregiver to explain the medication plan in their own words to confirm understanding of doses, frequencies, and key side effects.
  • Provide Clear Instructions: Use plain language and provide written instructions, medication calendars, and demonstrations for any new devices (e.g., inhalers, injection pens).
  • Arrange Follow-Up: For high-risk patients, schedule a follow-up phone call from a pharmacist or nurse within 72 hours of discharge to address questions and reinforce education.

C. Structured Handoff Communication Tools

Clear communication between inpatient and outpatient providers is essential. Utilize standardized templates like SBAR (Situation, Background, Assessment, Recommendation) or dedicated discharge summaries to clearly note therapy changes, pending labs, required monitoring, and “red flag” symptoms that warrant urgent attention.

Pearl Icon A lightbulb, indicating a clinical pearl or key insight. Clinical Pearl: Pharmacist-Led Discharge +

Multiple studies demonstrate that dedicated pharmacist involvement in the discharge process reduces clinically significant medication errors by up to 60% and decreases 30-day hospital readmission rates. This is one of the highest-value interventions for improving patient safety at discharge.

4. Patient Education and Quality Improvement

Long-term recovery and prevention of future events depend on robust patient education and systematic quality improvement within the healthcare system.

Editor’s Note: While a full exploration is beyond the scope of this chapter, a comprehensive program must include the following components:

  • Patient and Community Education: Focus on poison prevention strategies (e.g., secure medication storage, use of child-resistant packaging), education on early signs of recurrence, and clear referral pathways to outpatient resources like poison control centers and mental health services.
  • Epidemiologic Reporting and Quality Improvement: Adhere to institutional and public health requirements for overdose case reporting. Track key surveillance metrics (e.g., overdose frequency, substances involved, patient outcomes) and use this data to drive multidisciplinary quality-improvement cycles that refine protocols and reduce recurrence.

References

  1. Kawaguchi Y, et al. Liberation from mechanical ventilation in critically ill patients. J Intensive Care. 2024;12(1):15.
  2. BTS/ICS guideline for the ventilatory management of acute respiratory failure. Thorax. 2016;71(Suppl 2):ii1–ii35.
  3. Marra A, Ely EW, Pandharipande PP, Patel MB. The ABCDEF Bundle in Critical Care. Crit Care Clin. 2017;33(2):225–243.
  4. Zhang S, Wang Y, Li Y, et al. Effectiveness of Bundle Interventions on ICU Delirium. Crit Care Med. 2021;49(2):e123–e132.
  5. Eldean TNN, et al. Effectiveness of the ABCDEF Bundle to Manage and Prevent Delirium in Mechanically Ventilated ICU Patients. Am J Crit Care. 2024;33(1):e1–e8.
  6. Lipovec A, et al. Effectiveness of pharmacist-led medication reconciliation on discharge errors. J Clin Pharm Ther. 2024;49(3):456–464.
  7. Baker SN, et al. Development of a Discharge Counseling and Medication Reconciliation Program Targeting High-Risk Pediatric Patients. J Pediatr Pharmacol Ther. 2024;29(1):12–20.
  8. Kwan JL, et al. Medication Reconciliation—Too Much or Not Enough? JAMA Netw Open. 2021;4(9):e2124189.
  9. Green TC, et al. Implementation and evaluation of interprofessional overdose review teams: a statewide pilot in Rhode Island. J Public Health Manag Pract. 2024.
  10. EXTRIP Workgroup. Extracorporeal treatment for lithium poisoning: recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol. 2015;10(5):875–887.
  11. American College of Medical Toxicology. ACMT position statement: duration of intravenous acetylcysteine therapy following acetaminophen overdose. J Med Toxicol. 2017;13(1):126–127.
  12. Doyon S, Klein-Schwartz W. Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose. Acad Emerg Med. 2009;16(1):34–39.